Biological, Diagnostic, and Therapeutic Insights from (Epi) Genomic Profiling of Pediatric Brain Tumors

A De Cola, A Foss, R Gilbertson… - Annual Review of …, 2024 - annualreviews.org
Pediatric brain tumors comprise a diverse set of diseases.(Epi) genomic analyses have
provided insights into the biology of these tumors, stratifying them into distinct subtypes with …

Mitochondrial metabolism: A moving target in hepatocellular carcinoma therapy

M Komza, JE Chipuk - Journal of Cellular Physiology, 2024 - Wiley Online Library
Mitochondria are pivotal contributors to cancer mechanisms due to their homeostatic and
pathological roles in cellular bioenergetics, biosynthesis, metabolism, signaling, and …

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

M Monje, J Mahdi, R Majzner, KW Yeom, LM Schultz… - Nature, 2024 - nature.com
Abstract H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the
disialoganglioside GD2 (ref.). Chimeric antigen receptor-modified T cells targeting GD2 …

Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials

K Vasan, NS Chandel - The Journal of Clinical Investigation, 2024 - Am Soc Clin Investig
The majority of cancer cells have a functional mitochondrial electron transport chain (ETC).
Mitochondrial complex I is the primary entry point into the ETC, where oxidative …

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

I Arrillaga-Romany, SL Gardner, Y Odia… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Histone 3 (H3) K27M–mutant diffuse midline glioma (DMG) has a dismal
prognosis with no established effective therapy beyond radiation. This integrated analysis …

[HTML][HTML] Gliomas

FB Mesfin, T Karsonovich, MA Al-Dhahir - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Gliomas - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

A road map for the treatment of pediatric diffuse midline glioma

C Koschmann, WN Al-Holou, MM Alonso, J Anastas… - Cancer cell, 2024 - cell.com
Recent clinical trials for H3K27-altered diffuse midline gliomas (DMGs) have shown much
promise. We present a consensus roadmap and identify three major barriers:(1) refinement …

Discovery of dehydrogenated imipridone derivatives as activators of human caseinolytic protease P

J Jiang, G Xie, T Li, H Ding, R Tang, J Luo… - Journal of Medicinal …, 2024 - ACS Publications
Based on the founding member of imipridones, ONC201, a class of dehydrogenated
imipridone derivatives was designed, synthesized, and evaluated in a series of biochemical …

[HTML][HTML] ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells

J Cao, F Cao, C Wang, Z Jiao, Y You, X Wang, W Zhao - Neoplasia, 2024 - Elsevier
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for
approximately 90% of all cases. ONC201, a member of the imipridone drug family, has …

Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma

C Sojka, HLV Wang, TN Bhatia, Y Li, P Chopra… - Nature Cell …, 2025 - nature.com
Glioblastoma (GBM) is defined by heterogeneous and resilient cell populations that closely
reflect neurodevelopmental cell types. Although it is clear that GBM echoes early and …